Ramp1 Calcium gene-related peptide (CGRP) is a potent neuropeptide with widespread distribution throughout the human body, playing a crucial role in various physiological processes, most notably vasodilation. While CGRP is involved in functions like regulating blood pressure, heart rate, and respiratory control, its significant involvement in pain transmission, particularly in the context of migraine headaches, has garnered considerable attention. Understanding CGRP's function is essential for comprehending its implications in health and disease, and it has become a primary target for novel therapeutic interventionsCalcitonin gene-related peptide and adrenomedullin ....
CGRP is a 37-amino acid peptide that originates from the calcitonin gene through alternative RNA processing.作者：A Bonura·2023·被引用次数：23—Thecalcitonin gene-related peptide (CGRP) is a neuropeptide widely distributed throughout the human body. While primarily recognized as a ... It exists in two main isoforms, alpha-CGRP (α-CGRP) and beta-CGRP (β-CGRP), encoded by the CALCA and CALCB genes, respectively. These peptides are released from sensory nerves and are known for their potent vasodilatory effects, meaning they can widen blood vessels. This action is mediated through specific receptors, such as the CGRP1 receptor complex involving CALCRL and RAMP1. Beyond its vascular effects, CGRP is also implicated in modulating inflammatory responses and plays a role in bone metabolism, though its connection to osteoporosis is still an area of research.
The association between CGRP and migraine is well-established.Protective Role of α-Calcitonin Gene-Related Peptide in ... During a migraine attack, CGRP is released from trigeminal nerve endings, leading to vasodilation of cranial blood vesselsCalcitonin Gene Related Peptide, CGRP (alpha), human. This vasodilation is thought to contribute to the throbbing pain characteristic of migraines. Furthermore, CGRP can also promote neurogenic inflammation, further exacerbating migraine symptoms. This understanding has paved the way for developing targeted therapies that aim to block the action of CGRP or its receptor, offering a new avenue for migraine management.
The significant role of CGRP in migraine has led to the development of a new class of migraine medications known as CGRP inhibitors and CGRP monoclonal antibodies (mAbs). These therapies are designed to either block the CGRP molecule itself or its receptor, thereby preventing or reducing the frequency and severity of migraine attacks.2018年9月12日—CGRP1/CALCA is a peptide hormonethat induces vasodilation mediated by the CALCRL-RAMP1 receptor complex.
* CGRP Monoclonal Antibodies (mAbs): These are preventive medications administered via injection. They target either the CGRP molecule or its receptor and are used to reduce the number of migraine days. Examples include drugs that target the CGRP receptor.Targeting cPLA2 enzyme may reduce brain inflammation in ...
* CGRP Receptor Antagonists (Gepants): These are oral medications that block the CGRP receptor. They can be used for both acute treatment of migraine attacks and, in some cases, for prevention. Galcanezumab is an example of a CGRP antagonist.
* CGRP Inhibitors: This broader category encompasses medications that interfere with CGRP's activity.2023年9月26日—CGRP is a protein that helps control blood vessel expansion. It has functions all over the body but is of particular interest to people seeking treatment for ... They work by blocking the effect of CGRP, which is a small protein prevalent in sensory nerves.
These CGRP-targeting therapies represent a significant advancement in migraine treatment, offering hope to individuals who have not found relief with traditional medications.
While migraine is the most prominent condition linked to CGRP, research suggests its involvement in other physiological processes as well. Its vasodilatory properties have implications for cardiovascular health, and ongoing studies are exploring its potential therapeutic role in conditions like osteoporosis, where it may modulate neural-bone interactions.Calcitonin gene-related peptide (CGRP) is part of the calcitonin family of peptides, which in humans exists in two forms, alpha-CGRP and beta-CGRP. The complex interplay of CGRP with other neuropeptides like adrenomedullin also warrants further investigation to fully understand its systemic effects.Calcitonin gene-related peptide is potential therapeutic ... As our knowledge of CGRP expands, it is likely that its therapeutic potential will be further realized across a broader spectrum of medical conditions.
Join the newsletter to receive news, updates, new products and freebies in your inbox.